Education
About Us
Working with TipRanks
Follow Us
H. Miles Prince Insider Profile
4 Followers
H. Miles Prince, Director at Chimeric Therapeutics Ltd., holds 4.27M shares in Chimeric Therapeutics Ltd. (Ticker: AU:CHM). Most recently, H. Miles Prince Bought 4,273,142 shares of Chimeric Therapeutics Ltd. on Aug 21, 2025 for an estimated value of AU$14.96K.
H. Miles Prince has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
H. Miles Prince does not currently own shares as a corporate insider.
A breakdown of H. Miles Prince's holdings
Insider Roles
Director
Roles that H. Miles Prince holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by H. Miles Prince
H. Miles Prince's Trading History
List of latest transactions for each holding click on a transaction to see H. Miles Prince's performance on stock
You May Also Like
H. Miles Prince insider profile FAQ
What is the percentage of profitable transactions made by H. Miles Prince?
The percentage of profitable transactions made by H. Miles Prince is ―.
What is the average return per transaction made by H. Miles Prince?
The average return per transaction made by H. Miles Prince is ―.
What stocks does H. Miles Prince hold?
H. Miles Prince holds: AU:CHM stocks.
What was H. Miles Prince’s latest transaction?
H. Miles Prince latest transaction was an Informative Buy of AU$14.96K.
What was H. Miles Prince's most profitable transaction?
H. Miles Prince’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is H. Miles Prince's role in Chimeric Therapeutics Ltd.?
H. Miles Prince's role in Chimeric Therapeutics Ltd. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.